101 related articles for article (PubMed ID: 16565233)
1. The -318 C>G single-nucleotide polymorphism in GNAI2 gene promoter region impairs transcriptional activity through specific binding of Sp1 transcription factor and is associated with high blood pressure in Caucasians from Italy.
Menzaghi C; Paroni G; De Bonis C; Soccio T; Marucci A; Bacci S; Trischitta V
J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S115-9. PubMed ID: 16565233
[TBL] [Abstract][Full Text] [Related]
2. The Sp1 transcription factor binds to the G-allele of the -1087 IL-10 gene polymorphism and enhances transcriptional activation.
Larsson L; Johansson P; Jansson A; Donati M; Rymo L; Berglundh T
Genes Immun; 2009 Apr; 10(3):280-4. PubMed ID: 18843277
[TBL] [Abstract][Full Text] [Related]
3. Characterization of human collagen XVIII promoter 2: interaction of Sp1, Sp3 and YY1 with the regulatory region and a SNP that increases transcription in hepatocytes.
Armelin-Correa LM; Lin CJ; Barbosa A; Bagatini K; Winnischofer SM; Sogayar MC; Passos-Bueno MR
Matrix Biol; 2005 Dec; 24(8):550-9. PubMed ID: 16229994
[TBL] [Abstract][Full Text] [Related]
4. A point mutation affecting an SP1 binding site in the promoter of the ferrochelatase gene impairs gene transcription and causes erythropoietic protoporphyria.
Di Pierro E; Cappellini MD; Mazzucchelli R; Moriondo V; Mologni D; Zanone Poma B; Riva A
Exp Hematol; 2005 May; 33(5):584-91. PubMed ID: 15850836
[TBL] [Abstract][Full Text] [Related]
5. Functional haplotypes in the promoter of matrix metalloproteinase-2 predict risk of the occurrence and metastasis of esophageal cancer.
Yu C; Zhou Y; Miao X; Xiong P; Tan W; Lin D
Cancer Res; 2004 Oct; 64(20):7622-8. PubMed ID: 15492291
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional activity and Sp 1/3 transcription factor binding to the P1 promoter sequences of the human AbetaH-J-J locus.
Feriotto G; Finotti A; Breveglieri G; Treves S; Zorzato F; Gambari R
FEBS J; 2007 Sep; 274(17):4476-90. PubMed ID: 17681019
[TBL] [Abstract][Full Text] [Related]
7. The G/G genotype of a single nucleotide polymorphism at -1066 of c-Jun N-terminal kinase 1 gene (MAPK8) does not affect type 2 diabetes susceptibility despite the specific binding of AP2alpha.
Osawa H; Yamada K; Tabara Y; Ochi M; Onuma H; Nishida W; Shimizu I; Kawamoto R; Fujii Y; Miki T; Ohashi J; Makino H
Clin Endocrinol (Oxf); 2008 Jul; 69(1):36-44. PubMed ID: 18036196
[TBL] [Abstract][Full Text] [Related]
8. The -980C/G polymorphism in APH-1A promoter confers risk of Alzheimer's disease.
Qin W; Jia L; Zhou A; Zuo X; Cheng Z; Wang F; Shi F; Jia J
Aging Cell; 2011 Aug; 10(4):711-9. PubMed ID: 21443683
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional regulation of the hepatocyte growth factor (HGF) gene by the Sp family of transcription factors.
Jiang JG; Chen Q; Bell A; Zarnegar R
Oncogene; 1997 Jun; 14(25):3039-49. PubMed ID: 9223667
[TBL] [Abstract][Full Text] [Related]
10. A novel T-77C polymorphism in DNA repair gene XRCC1 contributes to diminished promoter activity and increased risk of non-small cell lung cancer.
Hao B; Miao X; Li Y; Zhang X; Sun T; Liang G; Zhao Y; Zhou Y; Wang H; Chen X; Zhang L; Tan W; Wei Q; Lin D; He F
Oncogene; 2006 Jun; 25(25):3613-20. PubMed ID: 16652158
[TBL] [Abstract][Full Text] [Related]
11. A functional SNP in the promoter region of TCOF1 is associated with reduced gene expression and YY1 DNA-protein interaction.
Masotti C; Armelin-Correa LM; Splendore A; Lin CJ; Barbosa A; Sogayar MC; Passos-Bueno MR
Gene; 2005 Oct; 359():44-52. PubMed ID: 16102917
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenetic interaction between paraoxonase-1 gene promoter polymorphism C-107T and statin.
Deakin S; Guernier S; James RW
Pharmacogenet Genomics; 2007 Jun; 17(6):451-7. PubMed ID: 17502837
[TBL] [Abstract][Full Text] [Related]
13. Detection and functional analysis of an SNP in the promoter of the human ferritin H gene that modulates the gene expression.
Faniello MC; Fregola A; Nisticò A; Quaresima B; Crugliano T; Faraonio R; Puzzonia P; Baudi F; Parlato G; Cuda G; Morrone G; Venuta S; Costanzo F
Gene; 2006 Aug; 377():1-5. PubMed ID: 16797877
[TBL] [Abstract][Full Text] [Related]
14. A single nucleotide polymorphism alters the sequence of SP1 binding site in the adiponectin promoter region and is associated with diabetic nephropathy among type 1 diabetic patients in the Genetics of Kidneys in Diabetes Study.
Zhang D; Ma J; Brismar K; Efendic S; Gu HF
J Diabetes Complications; 2009; 23(4):265-72. PubMed ID: 18599322
[TBL] [Abstract][Full Text] [Related]
15. Sp1 binds to the G allele of the-1087 polymorphism in the IL-10 promoter and promotes IL-10 mRNA transcription and protein production.
Larsson L; Rymo L; Berglundh T
Genes Immun; 2010 Mar; 11(2):181-7. PubMed ID: 20072143
[TBL] [Abstract][Full Text] [Related]
16. A functional common polymorphism in a Sp1 recognition site of the epidermal growth factor receptor gene promoter.
Liu W; Innocenti F; Wu MH; Desai AA; Dolan ME; Cook EH; Ratain MJ
Cancer Res; 2005 Jan; 65(1):46-53. PubMed ID: 15665278
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional regulation of the human FPR2/ALX gene: evidence of a heritable genetic variant that impairs promoter activity.
Simiele F; Recchiuti A; Mattoscio D; De Luca A; Cianci E; Franchi S; Gatta V; Parolari A; Werba JP; Camera M; Favaloro B; Romano M
FASEB J; 2012 Mar; 26(3):1323-33. PubMed ID: 22131270
[TBL] [Abstract][Full Text] [Related]
18. A variant in the CHEK2 promoter at a methylation site relieves transcriptional repression and confers reduced risk of lung cancer.
Zhang S; Lu J; Zhao X; Wu W; Wang H; Lu J; Wu Q; Chen X; Fan W; Chen H; Wang F; Hu Z; Jin L; Wei Q; Shen H; Huang W; Lu D
Carcinogenesis; 2010 Jul; 31(7):1251-8. PubMed ID: 20462940
[TBL] [Abstract][Full Text] [Related]
19. A common atopy-associated variant in the Th2 cytokine locus control region impacts transcriptional regulation and alters SMAD3 and SP1 binding.
Kretschmer A; Möller G; Lee H; Laumen H; von Toerne C; Schramm K; Prokisch H; Eyerich S; Wahl S; Baurecht H; Franke A; Claussnitzer M; Eyerich K; Teumer A; Milani L; Klopp N; Hauck SM; Illig T; Peters A; Waldenberger M; Adamski J; Reischl E; Weidinger S
Allergy; 2014 May; 69(5):632-42. PubMed ID: 24661001
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms in the osteopontin promoter affect its transcriptional activity.
Giacopelli F; Marciano R; Pistorio A; Catarsi P; Canini S; Karsenty G; Ravazzolo R
Physiol Genomics; 2004 Dec; 20(1):87-96. PubMed ID: 15479859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
